Arca
Skip to content
Tools
Tools

-azone

Anti-inflammatory painkillers related to phenylbutazone.

  • Drugs ending in -azone: 17
  • Approved somewhere: 9
  • With a US drug page: 6

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-azone
Class
Anti-inflammatory painkillers related to phenylbutazone
Sub-stem of
-buzone: Anti-inflammatory painkillers related to phenylbutazone
Most common targets
SLC12A3 (2), Bacterial penicillin-binding protein (1), DNA (1), SLC22A12 (1), KCNN4 (1), PTGS1, PTGS2 (1), PPARG (1)

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -azone, matched by spelling; those with a US drug page link to it.
Acts on
CefoperazoneApprovedBacterial penicillin-binding proteinBacterial penicillin-binding protein inhibitor
MetolazoneApprovedSLC12A3Thiazide-sensitive sodium-chloride cotransporter inhibitor
NitrofurazoneApprovedDNADNA inhibitor
QuinethazoneApprovedSLC12A3Thiazide-sensitive sodium-chloride cotransporter inhibitor
SulfinpyrazoneApprovedSLC22A12Solute carrier family 22 member 12 inhibitor
Chlorzoxazone—KCNN4Intermediate conductance calcium-activated potassium channel protein 4 opener
ApazoneApprovedPTGS1, PTGS2Cyclooxygenase inhibitor
FeprazoneApproved—Unknown
NaftazoneApproved——
PropyphenazoneApproved——
MitoguazonePhase 3——
CefbuperazonePhase 2——
EfatutazonePhase 2PPARGPeroxisome proliferator-activated receptor gamma agonist
MethisazonePhase 2——
NifenazonePhase 2——
ProquazonePhase 2——
SulfamazonePhase 2——

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.